News

New heart valve guideline has more accessible format

Publish date: March 17, 2014

 

FROM CIRCULATION AND THE JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dr. Nishimura and Dr. Otto reported no financial conflicts of interest; their associates on the ACC/AHA Task Force’s writing committee reported ties to Edwards Scientific, Medtronic, and St. Jude Medical.

Pages

Recommended Reading

FDA reviewers support approval of platelet inhibitor cangrelor for PCI indication
MDedge Cardiology
Mini-VADs could transform heart failure therapy
MDedge Cardiology
Novel procedure reduced need for aortic valve replacement in UAV patients
MDedge Cardiology
FDA panel votes against cangrelor approval for PCI, bridge indications
MDedge Cardiology
Ablation edges out drugs for treatment-naive paroxysmal atrial fibrillation
MDedge Cardiology
RAS blocker prescriptions still lag for ACS patients
MDedge Cardiology
Minimalist transfemoral TAVR winning surgical converts
MDedge Cardiology
Calculate an STS score before all aortic valve replacements
MDedge Cardiology
Wait! Put elective surgery on hold after stent placement
MDedge Cardiology
First guidelines on pulmonary hypertension in sickle cell disease released
MDedge Cardiology